Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
2(14%)
Results Posted
56%(5 trials)

Phase Distribution

Ph not_applicable
5
36%
Ph phase_4
3
21%
Ph early_phase_1
1
7%
Ph phase_3
5
36%

Phase Distribution

1

Early Stage

0

Mid Stage

8

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 3Large-scale testing
5(35.7%)
Phase 4Post-market surveillance
3(21.4%)
N/ANon-phased studies
5(35.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(9)
Terminated(1)
Other(2)

Detailed Status

Completed9
unknown2
Active, not recruiting1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.1%)
Phase 35 (35.7%)
Phase 43 (21.4%)
N/A5 (35.7%)

Trials by Status

active_not_recruiting17%
completed964%
recruiting17%
withdrawn17%
unknown214%

Recent Activity

2 active trials
Showing 5 of 14
recruitingnot_applicable

A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

NCT03472157
active_not_recruitingearly_phase_1

Vyvanse in Children Aged 6 to 12 Years

NCT05416125
completedphase_3

Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors

NCT04221750
completednot_applicable

Weight Loss Interventions for Black Adults of Faith

NCT04557540
completedphase_3

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira

NCT03862716
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT03472157Not Applicable

A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

Recruiting
NCT05416125Early Phase 1

Vyvanse in Children Aged 6 to 12 Years

Active Not Recruiting
NCT04221750Phase 3

Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors

Completed
NCT04557540Not Applicable

Weight Loss Interventions for Black Adults of Faith

Completed
NCT03862716Phase 3

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira

Completed
NCT04290962Not Applicable

Web-Based Lifestyle Intervention for the Improvement of Health in African American Cancer Survivors

Withdrawn
NCT02367105Phase 3

Lifestyle Intervention and Testosterone Replacement in Obese Seniors

Completed
NCT02623998Phase 3

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

Completed
NCT03430284Phase 4

Multifactorial Intervention on Diabetes (MIDiab Study)

Unknown
NCT02561130Phase 4

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga

Completed
NCT03130426Phase 3

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi

Completed
NCT01181674Phase 4

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

Completed
NCT01766037Not Applicable

Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study

Completed
NCT02881684Not Applicable

Aspiration Therapy in Asian Patients

Unknown

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14